CVS Health works with Piedmont Healthcare to help create hospital bed capacity in Georgia

Top of the article

Coram, the infusion care business of CVS Health, expands strategy to help transition eligible IV-therapy patients from hospitals to in-home nursing in Georgia during the pandemic

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) is working with Piedmont Healthcare in Georgia to support their solutions for increasing hospital bed capacity. This expands a recently launched strategy of Coram, the company’s infusion care business, to help transition eligible IV-therapy patients to home-based nursing care in response to COVID-19. Specifically, Coram has enhanced its clinical monitoring, virtual support and oversight through telehealth to complement existing personalized in-home support, coordination and administration of medications and supplies. In states like Georgia, ensuring the ability of hospital and health systems to handle potential surges of COVID-19 patients has become a critical factor in assessing stay-at-home orders and reopening local economies.https://gov.georgia.gov/press-releases/2020-04-20/gov-kemp-updates-georgians-covid-19

“Coram can deliver a clinically appropriate in-home care setting, which can be the safest place for patients recovering from a range of illnesses during this time by helping to minimize their risk of contracting COVID-19,” said Sree Chaguturu, M.D., Chief Medical Officer of CVS Caremark and CVS Specialty. “Our Coram model allows us to deploy clinical teams where the need is greatest, and we are shifting resources to support Piedmont Healthcare as a critical part of their solution to build and maintain hospital bed capacity for treating the critically ill impacted by the virus.”

Coram is working with Piedmont Healthcare to identify and begin transitioning stable patients to home-based nursing care. Patients with a range of conditions that may require infusion therapy, including hydration and nutritional support, anti-infectives and/or specialty medications for chronic condition management, will be considered. Once home, Coram’s specialized nurses will provide and coordinate a range of care, including daily visits and monitoring, medication administration, IV catheter line care, lab draws and educational support via telehealth. Coram is scaling this approach nationwide in other markets with high rates of COVID-19 cases, and working with home health agencies to enable care for patients with high acuity needs that may require additional clinical oversight and monitoring.

“During these extraordinary and unprecedented times, we remain focused on serving Georgians’ health care needs and have implemented a number of strategies that enable continuity of care for our patients and communities,” Robert Miller, M.D., Medical Director of Wound Care and Hyperbarics, Chair of the Board Piedmont Atlanta Hospital. “Together, with companies like CVS Health, we can employ innovative solutions that create the additional care capacity we need to help Georgians get through this.”

More information on the steps that CVS Health is taking to address the COVID-19 pandemic is available at the company’s frequently updated COVID-19 resource center.

About CVS Health 

CVS Health employees are united around a common goal of becoming the most consumer-centric health company in the world. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings – from HealthHUB® locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions – are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at https://www.cvshealth.com.

Media contact

Christina Beckerman
CVS Health
401-479-6570
christina.beckerman@cvshealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
4
Display Hero
Off
CSR Pillars
Locations
Audience

Home care dietitians improve tube feeding patient outcomes

Bottom of the article

Coram’s research highlights the critical role home care dietitians play in decreasing tube feeding intolerance and improving nutrition outcomes

Home-based health care continues to gain traction as an option for people living with a variety of chronic conditions. In fact, home infusion care can be a safe and cost-effective treatment alternative when compared to the same care provided in an in-patient or hospital setting. Coram CVS Specialty Infusion Services (Coram) is leading the way in home infusion care and parenteral (intravenous) and enteral (tube feeding) nutrition with a team of skilled home care Registered Dietitians, who can address nutrition intolerance, assess adequacy of hydration in feeding regimens, and address associated patient questions.

To advance the knowledge of health care practitioners and improve care for patients, Coram is actively involved in home nutrition care research. This research includes evaluating the impact of transitioning nutrition care from the hospital to the home and the benefits of home-based parenteral and enteral nutrition in certain populations.

Coram dietitians Nicki Bray, MS, RD, LDN; Sarah Allen MS, RD, LDN; and Caitlin Wendecker, RD, CNSC, recently conducted research to evaluate the efficacy of home care dietitian recommendations in addressing reported enteral nutrition intolerances, and the critical role home care dietitians play in creating interventions to improve nutrition outcomes. They shared their findings in their abstract, Home Care Dietitian Intervention Effectiveness to Reported Intolerance.

When patients are sent home from the hospital with little additional support and potentially poor tolerance to tube feedings, their outlook and compliance with their home tube feeding regimen may be impacted. Identifying and effectively addressing intolerance will increase a patient’s compliance and improve nutrition outcomes.

Coram conducted a retrospective review of adult patient records that reported intolerance within 48 hours of start of care. This retrospective review supported the important role of home care dietitians in evaluating and managing tube feeding intolerance, with dietitian interventions effective for 72% of patients by day 30 and 91% of patients by day 60. Without appropriate intervention by a dietitian, patients may be at risk for poor nutrition outcomes such as gastrointestinal distress, malnutrition, weight loss or underfeeding.

Home enteral nutrition patients are also at increased risk for dehydration due to inadequate fluid administration, and Coram dietitians explored this in an additional abstract, Adequacy of Flushing Orders in Home Enteral Nutrition Patients, by Katrina Sesler, MS, RD, CNSC; Rebecca Caldwell, MS, RD, LDN; and Laura Kashtan, RD, which reviewed patients’ water flushing orders at discharge from facility to home care. From a retrospective chart review of adult patients, Coram dietitians noted that discharge flush orders are missing or are inadequate for a considerable number of home enteral nutrition patients. Individualized recommendations and early patient contact by a dietitian may be important to prevent dehydration in these patients.

Early intervention by home care dietitians can help patients address tube feeding intolerance, assess hydration levels, improve therapy compliance and address patient questions and concerns. This support can help improve patient outcomes, potentially preventing hospital readmission at a time when hospital resources are stretched due to the increasing rate of COVID-19 admissions. Measures to help patients remain home and avoid hospital readmission are always valuable, but today they are critical.

A practitioner, using a tablet computer, assists a patient with tube feeding therapy.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
4
Display Hero
On
CSR Pillars
Audience

CVS Health works with UCLA Health and other hospitals to help create bed capacity

CVS Health works with UCLA Health and other hospitals to help create bed capacity
Top of the article

Coram, the company’s infusion care business, will help transition eligible IV-therapy patients out of the hospital and other care settings by providing in-home nursing

Woonsocket, R.I. — CVS Health (NYSE: CVS) is working with hospitals and providers, including UCLA Health, to support solutions for creating much-needed hospital bed capacity during the pandemic. Coram has enhanced its existing home infusion capacity and capabilities to help transition eligible IV-therapy patients to home-based care. This includes enhanced clinical monitoring, virtual support and oversight through telehealth to complement existing personalized in-home support, coordination and administration of medications and supplies. In California, the state is working to add 50,000 hospital beds to make enough room for anticipated COVID-19 patients.https://www.gov.ca.gov/2020/04/06/governor-newsom-announces-progress-in-expanding-hospital-capacity-to-fight-coming-surge-in-covid-19-cases/

“We’re able to create a clinically appropriate and safe in-home care setting, so hospitals can focus on treating those impacted by COVID-19,” said Sree Chaguturu, M.D., Chief Medical Officer of CVS Caremark and CVS Specialty. “Amid this unprecedented public health challenge, home can be the safest place for patients recovering from a range of illnesses and can also help minimize their risk of contracting COVID-19.”

Coram is working with UCLA Health to identify and begin transitioning stable patients to home-based nursing care. Patients with a range of conditions that may require infusion therapy, including hydration and nutritional support, anti-infectives and/or specialty medications for chronic condition management, will be considered. Once home, Coram’s specialized nurses will provide and coordinate a range of care, including daily visits and monitoring, medication administration, IV catheter line care, lab draws and educational support via telehealth. Coram is scaling this approach nationwide in other markets with high rates of COVID-19 cases, and working with home health agencies to enable care for patients with high acuity needs that may require additional clinical oversight and monitoring.

“Unprecedented challenges require innovative thinking and partnership as well as swift action,” said Prem Shah, Pharm.D., Executive Vice President of CVS Specialty and Product Innovation. “We’re deploying our clinical teams where the need is greatest, and our Coram nurses are doing an incredible job to help alleviate pressure on hospital capacity in some of the hardest-hit areas, including Los Angeles.” 

More information on the steps that CVS Health is taking to address the COVID-19 pandemic is available at the company’s frequently updated COVID-19 resource center.

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company in the world. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings – from HealthHUB® locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions – are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at https://www.cvshealth.com.

Media contact

Christina Beckerman
401-479-6570
christina.beckerman@cvshealth.com

A photo of a female physician reading a tablet computer in a hospital corridor.
Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
3
Display Hero
On
Topics
Audience

Supporting the Fight Against HIV/AIDS

Bottom of the article

This World AIDS Day, CVS Health is recognizing the progress made in the fight against HIV/AIDS and is teaming up with the U.S. Department of Health and Human Services (HHS) to help further reduce the spread of the HIV virus.

Reducing transmission of HIV

Currently, there are an estimated 1.1 million people in the U.S. living with HIV, and approximately 38,000 people diagnosed annually. Scientific advances over the past few decades have changed the paradigm for the prevention and treatment of the disease. For example, an HIV diagnosis is no longer a death sentence and can now be effectively managed through maintenance medications. In addition, more recent medical breakthroughs have brought to market pre-exposure prophylaxis (PrEP) medications that can prevent at-risk populations, including those who could contract the virus through sexual contact or drug use, from ever getting HIV.

HHS estimates that more than one million people in the U.S. could benefit from taking PrEP medication, however only 100,000 actually have a prescription. That is why CVS Health is teaming up with HHS to help make PrEP medication more accessible and affordable through a new HHS program called Ready, Set, PrEP, which is a key component of the Ending the HIV Epidemic In America initiative, which aims to reduce the number of new HIV infections in the U.S. by 90 percent over the next 10 years.

How it works

The HHS Ready, Set, PrEP program provides at-risk and HIV-negative individuals who do not have prescription drug coverage access to PrEP medication at no cost.  In addition, the program is providing education and awareness materials to help individuals gain more information about PrEP and learn how to access the Ready, Set, PrEP program. Once approved, and with a valid PrEP prescription from a health care provider, individuals can fill the medication at a participating pharmacy, including CVS Pharmacy and CVS Pharmacy Specialty Services locations or by mail. CVS Health has donated prescription dispensing services to HHS as part of Ready, Set, PrEP program. Those interested can learn more about Ready, Set, PrEP and apply online at GetYourPrep.com or calling toll-free 855-447-8410.

CVS Health has donated prescription dispensing services to HHS as part of Ready, Set, PrEP program. Those interested can learn more about Ready, Set, PrEP and apply online at GetYourPrep.com.
Tweet this

Our enterprise commitment

This is one more way that CVS Health is working to prevent the spread of HIV and help those living with HIV better manage the virus and prevent disease progression.

This includes an ongoing partnership with the Centers for Disease Control and Prevention (CDC) to help Act Against AIDS, which brings mobile HIV screening and testing services to CVS Pharmacy locations throughout the country.

In addition, through the CVS Specialty HIV Care Management program, patients can receive whole-patient management and support from nurses specially trained in HIV care.Nurse support is available to CVS Caremark members whose plans including Accordant Care Management (including CareTeam Choice or CareTeam Advanced) Comprehensive, continuous care can help promote medication adherence, improve outcomes, and reduce overall health costs. Further, at several CVS Pharmacy Specialty Services locations in New York City, HIV patients can receive proactive outreach to improve adherence to and management of HIV medications. This includes face-to-face counseling and/or telephonic outreach for all new-to-therapy patients; refill reminders; and additional co-morbidity and financial support and assistance, as appropriate.

Across CVS Health, we help support the HIV/AIDS community every day. Through high-touch support, screening and care management services, we help those who are at at-risk for or living with HIV/AIDS on their path to better health.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Audience

Accordant: Holistic Support for Patients with Complex Conditions

Bottom of the article
A photo of a doctor putting hand on patient’s shoulder.

Managing rare or complex conditions can often be challenging for patients. They can feel overwhelmed by the condition, medication side effects, complex dosage instructions, comorbidities, complicated provider directions, and experience challenges trying to navigate the health care system.

Health plans and employers, can adopt and offer our Accordant program for their plan members. Accordant provides holistic support for patients with rare conditions through targeted interventions designed to meet each patient’s unique needs.

The specialized care team is composed of registered nurses, pharmacists, social workers, and a medical director – all backed by a medical advisory board. These skilled practitioners set mutually agreed-upon health goals with the patient, discuss symptom management, explain proper use of medications, and even deal with resource issues such as lack of transportation to doctors’ appointments or cost of care. In addition, social workers help patients with community resources such as negotiating utility bill payments, identifying support groups, and grants for home modifications.

In a recent Blue Cross Blue Shield blog post, Accordant Medical Director Dr. Andrew Krueger discusses the importance of comprehensive care management services for patients with complex conditions such as multiple sclerosis and the difference this kind of care can make.

A photo showing a doctor putting hand on patient’s shoulder.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Audience

Improving the Infusion Therapy Experience with Coram

Bottom of the article

As health care costs continue to rise, payers, providers and patients are looking for new ways to help improve quality of patient care and their experience while lowering overall costs. One promising area is in home infusion care.

In fact, published research has shown that the home infusion services, like those provided by Coram CVS Specialty Services, can be safe and beneficial for those patients requiring infused therapies and in some cases can be a lower cost alternative to receiving the same services in a hospital or inpatient setting. In addition, the research has also shown that patients overwhelmingly prefer receiving their infusion therapies at home.

Read more about the benefits and value of home infusion care from Tricia Lacavich, Vice President for CVS Specialty Coram Infusion Services, in her recent article in Fierce Healthcare.

A patient and a caregiver sitting on a sofa.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Audience

Streamlining Prescription Onboarding with Specialty Expedite

Bottom of the article

As CVS Health looks to transform health care and contribute to a better, more efficient system, we are looking at ways to leverage and improve the use of technology to improve quality of care and patient outcomes.

This is especially important in specialty pharmacy and why we’ve introduced Specialty Expedite.Specialty Expedite is available exclusively for providers who use compatible electronic health record (EHR) systems including Epic Systems and others that participate in the Carequality Interoperability Framework. All data sharing and usage complies with applicable privacy laws. Patients receive real-time prescription status updates only after providing consent to CVS Specialty. Our connected capability transforms prescription onboarding for our CVS Specialty patients, on average shortening the specialty pharmacy onboarding process to as little as three days and ultimately helping to get patients started on appropriate therapy faster.

Getting Patients the Medications They Need Quickly and Efficiently

For patients with complex medical conditions requiring specialty medications, getting started on their prescriptions quickly and efficiently is crucial to their care. But the process has not always been that simple, with patients sometimes having to wait as long as several weeks to complete the manual onboarding and prior authorization process.

Specifically, the process to get started on a specialty medication often requires physician’s offices and insurers to fax appropriate patient records and/or required approvals before a prescription can be filled, which can be time consuming but is a critical step to ensure that patients are receiving the most appropriate medication.

In addition, across the health care system, the Federal government is looking at ways to help enable and improve health information technology (IT) systems and as part of that, officials have even called for health care to be a “fax free zone by 2020.”

How It Works

Specialty Expedite works by securely gathering appropriate patient information, including insurance, lab work and diagnosis codes via a doctor’s electronic health record (EHR) system instead of sharing through fax. The process also cuts down on paperwork and phone calls, resulting in fewer errors and more efficiencies.

In addition, patients also now have the option of receiving real-time status updates via email or text, so that they can stay informed on the status of their prescriptions and any prior authorization requirements. Patients are also able to choose how they want to get their specialty medications — at their local CVS Pharmacy or though specialty mail serviceWhere allowed by law. In-store pick up is currently not available in Oklahoma. Puerto Rico requires first-fill prescriptions to be transmitted directly to the dispensing specialty pharmacy. Products are dispensed by CVS Specialty and certain services are only accessed by calling CVS Specialty directly. Certain specialty medication may not qualify. Services are also available at Long’s Drugs locations. via Specialty Connect. Research shows that when patients have more flexibility and choice, they are able to start their therapies sooner and adherence and satisfaction improves.

Helping patients with complex medical conditions get the specialty medication they need more quickly and efficiently through technology and solutions such as Specialty Expedite is one more way we are helping people on their path to better health.

For more information about CVS Health’s efforts to improve care across the nation, visit our News & Insights page and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

A photo of a smiling pharmacist at computer.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
3
Display Hero
Off
Assets
Campaign
CSR Pillars
Audience

Supporting Our Patients with Chronic Disease

Bottom of the article
A doctor comforting a female patient.

As we transform the health care experience for all patients, we pay special attention to the needs of patients with chronic diseases who seek care more frequently. We continue to invest in the development of smart and robust solutions to address the health impacts and escalating costs related to chronic disease in the U.S. Our efforts include expanding preventive care and treatment for chronic conditions, improving medication adherence, coordinating care across the healthcare system, engaging patients where they are, and offering healthier product options at our stores.

Personalizing Care Solutions

Our Transform Care programs continue to deliver frequent and highly personalized care to millions of CVS Caremark members who are managing a chronic condition. The programs combine patient-related health and pharmacy data with drug cost management strategies that make care more effective, affordable and easy to navigate.

Transform Diabetes Care, introduced in 2016, has since been adopted by more than 230 CVS Caremark clients, representing 3.4 million members. The program uses advanced analytics to identify members with diabetes and target appropriate interventions. A certified coach develops and helps execute personalized management plans for Type 2 diabetes patients based on their pharmacy data and electronic health record information. The patients use at-home, connected glucometers for glucose readings, which their coach can monitor to offer help as needed. The program also ensures patients receive prescription refill reminders, in-person counseling on diabetes management, and comprehensive diabetes visits at MinuteClinic locations at no out-of-pocket cost.

By 2021, we plan to offer an enhanced diabetes program that combines CVS Health’s local and pharmacy care with Aetna’s care management, targeting, analytics and other capabilities, resulting in a best-in-class diabetes and chronic offering. The enhanced program will derive from the current Transform Diabetes Care model, making for a seamless transition and member experience for clients who wish to adopt the enhanced product. Features of the enhanced product may include:

Aetna’s care managers can provide a single point of contact for members with chronic conditions regardless of which conditions members have. The member’s care manager will also have access to the member’s information from their engagement in the Transform Diabetes Care program and can coach based off of that information.

Creating Comprehensive Programs for Complex Conditions

Another way we are reducing costs and enhancing patient care is through the development of comprehensive programming designed specifically for complex chronic conditions like kidney disease and cancer.

In 2018, we introduced a program to support patients with End Stage Renal Disease (ESRD), a disease that affects nearly 700,000 Americans. Taking a staged approach, our program seeks to slow the progression of ESRD and reduce associated hospitalizations. Beginning with early disease identification and patient education, the program will follow with the development of a comprehensive home dialysis program, for both hemodialysis and peritoneal dialysis. Understanding that longer, more frequent hemodialysis treatments often lead to better outcomes, we will initiate a pivotal clinical trial of a new home hemodialysis device in support of a planned U.S. Food and Drug Administration (FDA) submission to obtain market clearance.

We will select new program participants by determining who is most at risk for kidney disease and progression to kidney failure, as identified through medical and pharmacy claims data and predictive analytics algorithms, in accordance with HIPAA. Our Accordant Care nurses will engage these individuals to educate them on their risk level, important tests they should consider taking, and the need to see a nephrologist. This team will work with individuals as they progress toward ESRD.

We also work with our health care partners and clients to help manage the cost of oncology care while ensuring access to vital therapies for patients. Our approach promotes evidence-based cancer care, lower-cost but clinically equivalent treatment options, and a holistic patient care model that helps patients adhere to therapy. An important component of our cancer care approach is helping providers stay up-to-date with the latest research and advancements, a challenge in the fast-paced field of oncology.

In 2018, we partnered with the leading oncology organization National Comprehensive Cancer Network (NCCN) to provide physicians with a tool to access the latest evidence-supported information. Treatment Guidelines from the NCCN are integrated into Novologix, CVS Health’s proprietary technology platform, and serve as the clinical foundation of multi-drug regimen prior authorization (PA) for physicians and patients. Novologix helps drive cost-effective regimen selection by determining treatment coverage that meets treatment plan needs.

To learn about the many other ways we’re supporting our chronic disease patients, read our 2018 Corporate Social Responsibility Report.

To stay up-to-date on the latest CVS Health Social Responsibility news and content, sign up for email news alerts.

A doctor comforting a female patient.
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
5
Display Hero
Off
CSR Pillars
Audience

Clinical Secure Messaging Helps Improve Medication Adherence

Clinical Secure Messaging Helps Improve Medication Adherence
Bottom of the article
Graph showing Medication adherence improved in both groups of patients who used secure messaging.
Medication adherence improved in both groups of patients who used secure messaging.
Graph showing more optimal medication adherence with secure messaging.
Optimal medication adherence improved for both groups of patients using secure messaging.
Graph showing a decrease in the first-fill drop-off rate for patients using secure messaging.
First-fill drop-off rate also decreased among patients using secure messaging.

Historically, people with complex conditions may receive telephonic or in-person support from a specially trained nurse or pharmacist with the goal of helping the patient better manage their condition(s), take their medication(s) as prescribed and improve their overall health outcomes. In this increasingly digital age, however, people are turning to technology for help with a range of things, including health care.

Recognizing this shift toward digital engagement, CVS Specialty is bringing patients innovative digital and online tools to help them better manage their conditions and access additional support online. This includes secure, two-way messaging that puts a nurse or pharmacist at the patients’ fingertips.

Powering this capability is a proprietary, company-built tool loaded with therapy- and indication-specific clinical information. Patients opt-in to receive personalized message alerts via their mobile phone asking if they are experiencing certain common medication side effects. The messages are based on clinical trial data, the drug’s label and feedback from other patients, and are timed to reach the patient when they are more likely to experience a specific side effect. The message also includes a link to enable the patient to ask the pharmacist a medication-related question.

Following the launch of this tool for patients with chronic myeloid leukemia (CML), initial results were promising, with high engagement rates and improved medication adherence, compared to more traditional support methods, including telephonic outreach.

Scaling to Other Specialty Conditions

With positive results in patients with CML, CVS Specialty quickly expanded use of this tool across all specialty conditions and recently conducted a retrospective analysis of specialty pharmacy claims and use of secure messaging in patients with rheumatoid arthritis (RA) and multiple sclerosis (MS).

These findings were recently presented at the Academy of Managed Care Pharmacy annual meeting and showed that patients with these complex conditions can also benefit from this type of digital support when compared to more traditional support methods. Specifically, patients who received the customized, secure clinical messages on topics including adherence, condition management or side effect management, every 30 days, were more likely to re-fill their prescription(s) and achieved significantly higher medication adherence than the control group. In fact, optimal adherence for patients in the study with either MS or RA receiving this digital clinical support improved by 3.82% and 2.12% points, respectively.

At CVS Specialty, the goal is to help patients on their path to better health by offering support where and when patients need it most. This data shows the promise of clinical support delivered digitally and, as part of a health care innovation company, CVS Specialty is committed to continuing to help more patients manage their diseases in a way that meets their individual needs.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Audience

CVS Health and Omnicare Sign Definitive Agreement for CVS Health to Acquire Omnicare

Top of the article

WOONSOCKET, R.I.and CINCINNATI, May 21, 2015 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) and Omnicare, Inc. (NYSE:OCR) announced today that they have entered into a definitive agreement for CVS Health to acquire Omnicare, the leading provider of pharmacy services to long term care facilities, for $98.00 per share in cash, for a total enterprise value of approximately $12.7 billion, which includes approximately $2.3 billion in debt. In total, Omnicare has approximately 13,000 employees at 160 locations in 47 states across the U.S.

With the acquisition of Omnicare, CVS Health will significantly expand its ability to dispense prescriptions in assisted living and long term care facilities, serving the senior patient population. CVS Health will also expand its presence in the rapidly growing specialty pharmacy business. Omnicare's complementary specialty pharmacy platform and clinical expertise will augment CVS Health's capabilities and enable CVS Health to continue to provide innovative and cost-effective solutions to patients and payors.

The boards of directors of both companies have approved the transaction, which is subject to approval by the holders of Omnicare's common stock, as well as other customary closing conditions, including applicable regulatory approvals. The transaction is expected to close near the end of 2015.

CVS Health expects to achieve significant purchasing and revenue synergies as well as operating efficiencies from this combination. The company expects the transaction to be approximately 20 cents accretive to Adjusted EPS in 2016, its first full year, excluding integration and any one-time transaction costs. It is expected to become increasingly accretive to Adjusted EPS in subsequent years. The company has secured $13 billion in fully committed unsecured bridge financing from Barclays and expects to put in place permanent financing in the form of senior notes and/or term loans prior to the closing of the transaction. CVS Health expects that it will continue to have a solid balance sheet and, with its strong free cash flow, is committed to returning to its targeted leverage ratio of 2.7 times adjusted debt-to-EBITDA.

"The acquisition of Omnicare significantly expands our business, providing CVS Health access into a new pharmacy dispensing channel," said CVS Health President and CEO Larry Merlo. "It also creates new opportunities for us to extend our high-quality, innovative pharmacy programs to a broader population of seniors and chronic care patients as they transition across the care continuum. We have been impressed by the Omnicare team and what they have created for the patients they serve."

"We are pleased to have reached this agreement with CVS Health, one of the leading companies in the health care industry, which we believe will allow us to accelerate our mission of enhancing the quality and cost-effectiveness of care for complex patient populations," said Omnicare President and CEO Nitin Sahney. "This exciting combination is the result of a broad and thorough review of our strategic options. On behalf of the Omnicare team, I'd like to thank our 13,000 employees whose hard work and dedication has enabled Omnicare to become a recognized leader in pharmacy services."

Given the aging U.S. population, long term care is a growth segment of the health care system. More people are expected to use assisted living facilities and independent living communities in the coming decades, creating a substantial growth opportunity for those companies serving the health care needs of seniors.

In entering this new customer distribution channel, CVS Health will deliver meaningful benefits to consumers, patients, caregivers, and payors by providing highly coordinated clinical pharmacy care across multiple treatment settings from retail to long term care. CVS Health will help improve patient outcomes and provide enhanced continuity of care to patients and caregivers as they transition through the health care system.

CVS Health received investment banking and financial advice from Barclays and Evercore. The company was advised on transaction legal matters by Sullivan & Cromwell LLP and on antitrust matters by Dechert LLP.

BofA Merrill Lynch and Centerview Partners are serving as financial advisors to Omnicare. White & Case LLP is serving as Omnicare's legal counsel.

Teleconference and Webcast

CVS Health will be holding a conference call today for the investment community at 8:30 am (EDT) to discuss the transaction. The dial-in number for the call is 800-750-5849 or, for international callers, 212-231-2921. An audio webcast of the call will be broadcast simultaneously on CVS Health's website for all interested parties. To access the webcast, please visit the investor relations section of the company's website at http://investors.cvshealth.com/. A replay of the call will be available from approximately 10:30 am (EDT) on May 21 through 10:30 am (EDT) on May 28. It can be accessed by dialing 800-633-8284 or, for international callers, 402-977-9140, and entering access code 21769309. The webcast will be archived and available on the CVS Health website for a one-year period following the conference call.

About CVS Health
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

About Omnicare
Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group. For more information, visit www.omnicare.com.

Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the federal securities laws. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. These forward-looking statements may be identified by words such as 'believes', 'expects', 'anticipates', 'projects', 'intends', 'should', 'seeks', 'estimates', 'future' or similar expressions or by discussion of, among other things, strategy, goals, plans or intentions. The factors that could cause actual results to differ materially include the following: the possibility that the anticipated synergies and other benefits from the proposed acquisition of Omnicare by CVS Health will not be realized, or will not be realized within the expected time periods; the inability to obtain regulatory approvals of the proposed acquisition (including the approval of antitrust authorities necessary to complete the transaction) on the terms desired or anticipated; the timing of such approvals and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the transaction; the risk that a condition to closing the transaction may not be satisfied on a timely basis or at all; the risk that the proposed transaction fails to close for any other reason; the risks and uncertainties related to CVS Health's ability to successfully integrate the operations, products and employees of Omnicare; the effect of the potential disruption of management's attention from ongoing business operations due to the pending acquisition; the effect of the announcement of the proposed transaction on CVS Health's and Omnicare's relationships with their respective customers, vendors and lenders and on their respective operating results and businesses generally; access to available financing on a timely basis and on reasonable terms; the outcome of any legal proceedings related to the proposed acquisition; and the risks and uncertainties normally incidental to the respective businesses of CVS Health and Omnicare. Additional information concerning these and other risks and uncertainties can be found in CVS Health's and Omnicare's periodic reports filed with the U.S. Securities and Exchange Commission (the "SEC"). Copies of these filings, as well as subsequent filings, are available online at www.sec.gov, www.cvshealth.com, www.omnicare.com or on request from CVS Health or Omnicare, as applicable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as otherwise required by law, neither CVS Health nor Omnicare undertakes any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Additional Information and Where to Find It
This communication may be deemed to be solicitation material in respect of the proposed acquisition of Omnicare, Inc. by CVS Pharmacy, Inc., a wholly owned subsidiary of CVS Health Corporation. In connection with the proposed acquisition, CVS Health and Omnicare intend to file relevant materials with the SEC, including Omnicare's proxy statement on Schedule 14A. INVESTORS AND STOCKHOLDERS OF OMNICARE ARE ADVISED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING OMNICARE'S PROXY STATEMENT WHEN IT BECOMES AVAILABLE BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS WITH RESPECT TO THE PROPOSED ACQUISITION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the proxy statement (when available) and other relevant documents free of charge at the SEC's web site, http://www.sec.gov, and Omnicare stockholders will receive information at an appropriate time on how to obtain transaction-related documents for free from Omnicare.

Participants in Solicitation
CVS Health and its directors and executive officers, and Omnicare and its directors and executive officers, may be deemed to be participants in the solicitation of proxies from the holders of Omnicare common stock in connection with the proposed acquisition. Information about the directors and executive officers of CVS Health is set forth in the proxy statement for CVS Health's 2015 Annual Meeting of Stockholders, which was filed with the SEC on March 27, 2015. Information about the directors and executive officers of Omnicare is set forth in the proxy statement for Omnicare's 2015 Annual Meeting of Stockholders, which was filed with the SEC on April 17, 2015. Additional information regarding potential participants in such proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the proxy statement and other relevant materials filed by Omnicare with the SEC in connection with the proposed acquisition when they become available.

Contacts:

For CVS Health:
Nancy Christal
Senior Vice President
Investor Relations
(914) 722-4704

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717
Carolyn.Castel@CVSHealth.com

For Omnicare:
Patrick Lee
Senior Vice President
Investor Relations
(513) 719-1507
patrick.lee@omnicare.com

Logo- http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health Corporation

Press Release
"Likes" Count
0